News

Evoke Neuroscience aims to develop Artificial Intelligence biomarker for Alzheimer’s disease diagnosis

NEW YORK, NY, USA, November 8, 2019 /EINPresswire.com/ — Evoke Neuroscience, a medical device company developing and commercializing technologies to aid in diagnosis of cognitive disorders, announced today initial enrollment of subjects participating in an IRB approved study to develop an Artificial Intelligence (AI) biomarker of mild cognitive impairment (MCI) and Alzheimer’s disease (AD). Conducted at the Pacific Neuroscience Institute […]

Allied : Signs Letter of Intent with Evoke Neurosciences to Partner on the Analysis and Treatment of PTSD Patients

Allied Corp. (OTC Pink: ALID) (“Allied”), an international medical cannabis production company focused on creating and providing targeted cannabinoid health solutions, is pleased to announce its signing of a Letter Of Intent (“the LOI”) with Evoke Neurosciences (“Evoke”). Evoke’s eVox System generates an objective and automated report for clinicians and researchers to use as a baseline and to aid diagnosis […]

Evoke Neuroscience takes on TBI, PTSD with the US Air Force

NEW YORK CITY, NY, USA, September 10, 2019 /EINPresswire.com/ — Evoke Neuroscience has been awarded a working contract by the United States Air Force (USAF) for its diagnostic device, the eVox® System. The contract is part of the USAF Small Business Innovation Research (SBIR) Phase I program that provides the framework for a fully integrated solution with Air Force constituents. […]

Evoke Neuroscience to Present at ROTH Capital Conference

Evoke Neuroscience announces it has been selected to present to the attendees of this year’s ROTH Capital Conference on March 18 in Orange County, California. Evoke will present its eVox® System, the FDA-cleared device that aids physicians in the diagnosis of memory loss and other cognitive disorders, to a diverse group of clinicians, investors, and healthcare industry professionals. Evoke has […]

Evoke Neuroscience awarded People’s Choice Award at OCTANe’s Medical Technology Innovation Forum

NEW YORK, NEW YORK, USA, November 8, 2018 /EINPresswire.com/ – Evoke Neuroscience won the popular vote by attendees and took home the People’s Choice Award at OCTANe’s 13th Annual Medical Technology Innovation Forum. Recognized for its bold vision of eradicating dementia, Evoke Neuroscience was one of 8 companies selected out of 113 who applied to present via the OCTANe LaunchPad […]

Evoke Neuroscience to present at OCTANe’s 13th Annual Medical Technology Innovation Forum

NEW YORK, NY, USA, October 11, 2018 /EINPresswire.com/ – Evoke Neuroscience announces it has been selected to present to the attendees of this year’s Medical Technology Innovation Forum on October 29th in Newport Beach, California. Evoke will present its eVox System, which aids physicians in the diagnosis of memory loss and other cognitive disorders, to a diverse group of clinicians, […]

Evoke Neuroscience awarded Breakthrough Technology agreement with Premier

New York, NY, March 29, 2018 – Evoke Neuroscience has been awarded a group purchasing agreement as a breakthrough technology with Premier. Effective March 1, 2018, the agreement allows Premier members to take advantage of special pricing and terms pre-negotiated by Premier for the eVox® System, the medical device that assesses brain function to aid doctors in the diagnosis of […]

Evoke Neuroscience announces award of VA contract for the eVox® System

Evoke Neuroscience, Inc. is pleased to announce the award of a Veterans Health Administration Contract for the eVox® System. The Contract award #36F79718D0348 enables the VA and other federal organizations to purchase the eVox System at pre-approved pricing via the Veterans Administration’s FSS Contract, via GSA Advantage, or GSA eBUY. The eVox System measures brain health to aid doctors in […]

CISION iREACH

CISION iREACH – September 14, 2017 Evoke Neuroscience named to Inc. 5000 List of America’s Fastest-Growing Private Companies for Second Consecutive Year. Read the Full Article

The Silicon Review

The Silicon Review – May 15, 2017 Evoke Neuroscience named as one of 50 most valuable brands of the year 2017. Read the Full Article

© Copyright 2019 — Evoke Neuroscience, Inc.

Terms & Conditions | Privacy Policy | Interest-based Ads


ISO 13485 CertifiedThe eVox system is a Class II medical device that has received Section 510(K) clearance from the FDA. It is intended for the acquisition, display, and storage, of electrical activity of a patient’s brain including electroencephalograph (EEG) and event-related potentials (ERP) obtained by placing two or more electrodes on the head to aid in diagnosis.

Log in with your credentials

Forgot your details?